Autoreactive CD8


Journal

Nature immunology
ISSN: 1529-2916
Titre abrégé: Nat Immunol
Pays: United States
ID NLM: 100941354

Informations de publication

Date de publication:
06 2022
Historique:
received: 02 03 2022
accepted: 12 04 2022
pubmed: 27 5 2022
medline: 10 6 2022
entrez: 26 5 2022
Statut: ppublish

Résumé

Impaired chronic viral and tumor clearance has been attributed to CD8

Identifiants

pubmed: 35618829
doi: 10.1038/s41590-022-01210-5
pii: 10.1038/s41590-022-01210-5
pmc: PMC9179227
mid: NIHMS1798023
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

868-877

Subventions

Organisme : NCI NIH HHS
ID : P01 CA210944
Pays : United States
Organisme : NIAID NIH HHS
ID : F31 AI147638
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI144422
Pays : United States
Organisme : NIH HHS
ID : S10 OD011925
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI082630
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI112521
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI115712
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI089443
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK089125
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI108545
Pays : United States
Organisme : NIAID NIH HHS
ID : DP2 AI164325
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI105343
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI117950
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG012041
Pays : United States

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Nature America, Inc.

Références

Blank, C. U. et al. Defining ‘T cell exhaustion’. Nat. Rev. Immunol. 19, 665–674 (2019).
pubmed: 31570879 pmcid: 7286441 doi: 10.1038/s41577-019-0221-9
Beltra, J. C. et al. Developmental relationships of four exhausted CD8
pubmed: 32396847 pmcid: 8360766 doi: 10.1016/j.immuni.2020.04.014
Khan, O. et al. TOX transcriptionally and epigenetically programs CD8
pubmed: 31207603 pmcid: 6713202 doi: 10.1038/s41586-019-1325-x
Scott, A. C. et al. TOX is a critical regulator of tumour-specific T cell differentiation. Nature 571, 270–274 (2019).
pubmed: 31207604 pmcid: 7698992 doi: 10.1038/s41586-019-1324-y
Seo, H. et al. TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8
pubmed: 31152140 pmcid: 6589758 doi: 10.1073/pnas.1905675116
Yao, C. et al. Single-cell RNA-seq reveals TOX as a key regulator of CD8
pubmed: 31209400 pmcid: 6588409 doi: 10.1038/s41590-019-0403-4
Tilstra, J. S. et al. Kidney-infiltrating T cells in murine lupus nephritis are metabolically and functionally exhausted. J. Clin. Invest. 128, 4884–4897 (2018).
pubmed: 30130253 pmcid: 6205402 doi: 10.1172/JCI120859
Smita, S., Chikina, M., Shlomchik, M. J. & Tilstra, J. S. Heterogeneity and clonality of kidney-infiltrating T cells in murine lupus nephritis. JCI Insight https://doi.org/10.1172/jci.insight.156048 (2022).
Long, S. A. et al. Remodeling T cell compartments during anti-CD3 immunotherapy of type 1 diabetes. Cell Immunol. 319, 3–9 (2017).
pubmed: 28844471 pmcid: 5614459 doi: 10.1016/j.cellimm.2017.07.007
McKinney, E. F., Lee, J. C., Jayne, D. R., Lyons, P. A. & Smith, K. G. T cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection. Nature 523, 612–616 (2015).
pubmed: 26123020 pmcid: 4623162 doi: 10.1038/nature14468
Wiedeman, A. E. et al. Autoreactive CD8
pubmed: 31815738 doi: 10.1172/JCI126595
Long, S. A. et al. Partial exhaustion of CD8
Pauken, K. E., Dougan, M., Rose, N. R., Lichtman, A. H. & Sharpe, A. H. Adverse events following cancer immunotherapy: obstacles and opportunities. Trends Immunol. 40, 511–523 (2019).
pubmed: 31053497 pmcid: 6527345 doi: 10.1016/j.it.2019.04.002
Burke, K. P., Grebinoski, S., Sharpe, A. H. & Vignali, D. A. A. Understanding adverse events of immunotherapy: a mechanistic perspective. J. Exp. Med. https://doi.org/10.1084/jem.20192179 (2020).
Gearty, S. V. et al. An autoimmune stem-like CD8+ T cell population drives type 1 diabetes. Nature https://doi.org/10.1038/s41586-021-04248-x (2021).
Chen, Y. -G., Mathews, C. E. & Driver, J. P. The role of NOD mice in type 1 diabetes research: lessons from the past and recommendations for the future. Front. Endocrinol. https://doi.org/10.3389/fendo.2018.00051 (2018).
Christianson, S. W., Shultz, L. D. & Leiter, E. H. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4
pubmed: 8093606 doi: 10.2337/diab.42.1.44
Varela-Calvino, R., Calviño-Sampedro, C., Gómez-Touriño, I. & Cordero, O. J. Apportioning blame: autoreactive CD4
doi: 10.1007/s00005-016-0452-4
Yeo, L. et al. Autoreactive T effector memory differentiation mirrors β cell function in type 1 diabetes. J. Clin. Invest. 128, 3460–3474 (2018).
pubmed: 29851415 pmcid: 6063477 doi: 10.1172/JCI120555
Skowera, A. et al. β-cell-specific CD8
pubmed: 25249579 doi: 10.2337/db14-0332
Abdelsamed, H. A. et al. Beta cell-specific CD8
pubmed: 32231298 pmcid: 7183435 doi: 10.1038/s41590-020-0633-5
Zakharov, P. N., Hu, H., Wan, X. & Unanue, E. R. Single-cell RNA sequencing of murine islets shows high cellular complexity at all stages of autoimmune diabetes. J. Exp. Med. https://doi.org/10.1084/jem.20192362 (2020).
Bettini, M. et al. Cutting edge: accelerated autoimmune diabetes in the absence of LAG-3. J. Immunol. 187, 3493–3498 (2011).
pubmed: 21873518 doi: 10.4049/jimmunol.1100714
Kotecha, N., Krutzik, P. O. & Irish, J. M. Web-based analysis and publication of flow cytometry experiments. Curr. Protoc. Cytom. 10, 17 (2010).
pubmed: 20578106
Zhang, Q. et al. LAG3 limits regulatory T cell proliferation and function in autoimmune diabetes. Sci. Immunol. https://doi.org/10.1126/sciimmunol.aah4569 (2017).
Miller, B. C. et al. Subsets of exhausted CD8
pubmed: 30778252 pmcid: 6673650 doi: 10.1038/s41590-019-0312-6
Chee, J. et al. Effector-memory T cells develop in islets and report islet pathology in type 1 diabetes. J. Immunol. 192, 572–580 (2014).
pubmed: 24337380 doi: 10.4049/jimmunol.1302100
Kuric, E. et al. Demonstration of tissue-resident memory CD8
pubmed: 28212742 doi: 10.1016/j.ajpath.2016.11.002
Lennon, G. P. et al. T cell islet accumulation in type 1 diabetes is a tightly regulated, cell-autonomous event. Immunity 31, 643–653 (2009).
pubmed: 19818656 pmcid: 2763021 doi: 10.1016/j.immuni.2009.07.008
Paley, M. A. et al. Progenitor and terminal subsets of CD8
pubmed: 23197535 pmcid: 3653769 doi: 10.1126/science.1229620
Li, J., He, Y., Hao, J., Ni, L. & Dong, C. High levels of Eomes promote exhaustion of anti-tumor CD8
pubmed: 30619337 pmcid: 6305494 doi: 10.3389/fimmu.2018.02981
Seo, W., Jerin, C. & Nishikawa, H. Transcriptional regulatory network for the establishment of CD8
pubmed: 33627794 pmcid: 8080584 doi: 10.1038/s12276-021-00568-0
Canale, F. P. et al. CD39 expression defines cell exhaustion in tumor-infiltrating CD8
pubmed: 29066514 doi: 10.1158/0008-5472.CAN-16-2684
Gupta, P. K. et al. CD39 expression identifies terminally exhausted CD8
pubmed: 26485519 pmcid: 4618999 doi: 10.1371/journal.ppat.1005177
Bengsch, B. et al. Bioenergetic insufficiencies due to metabolic alterations regulated by the inhibitory receptor PD-1 are an early driver of CD8
pubmed: 27496729 pmcid: 4988919 doi: 10.1016/j.immuni.2016.07.008
Scharping, N. E. et al. Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion. Nat. Immunol. 22, 205–215 (2021).
pubmed: 33398183 pmcid: 7971090 doi: 10.1038/s41590-020-00834-9
Scharping, N. E. et al. The tumor microenvironment represses T cell mitochondrial biogenesis to drive intratumoral T cell metabolic insufficiency and dysfunction. Immunity 45, 701–703 (2016).
pubmed: 27653602 doi: 10.1016/j.immuni.2016.08.009
Sato, Y. et al. Cellular hypoxia of pancreatic beta-cells due to high levels of oxygen consumption for insulin secretion in vitro. J. Biol. Chem. 286, 12524–12532 (2011).
pubmed: 21296882 pmcid: 3069454 doi: 10.1074/jbc.M110.194738
Olsson, R., Olerud, J., Pettersson, U. & Carlsson, P.-O. Increased numbers of low-oxygenated pancreatic islets after intraportal islet transplantation. Diabetes 60, 2350–2353 (2011).
pubmed: 21788575 pmcid: 3161309 doi: 10.2337/db09-0490
Olsson, R. & Carlsson, P. O. A low-oxygenated subpopulation of pancreatic islets constitutes a functional reserve of endocrine cells. Diabetes 60, 2068–2075 (2011).
pubmed: 21788581 pmcid: 3142080 doi: 10.2337/db09-0877
Komatsu, H., Kandeel, F. & Mullen, Y. Impact of oxygen on pancreatic islet survival. Pancreas 47, 533–543 (2018).
pubmed: 29621044 pmcid: 5943071 doi: 10.1097/MPA.0000000000001050
Liao, Y., Wang, J., Jaehnig, E. J., Shi, Z. & Zhang, B. WebGestalt 2019: gene-set analysis toolkit with revamped UIs and APIs. Nucleic Acids Res. 47, W199–w205 (2019).
pubmed: 31114916 pmcid: 6602449 doi: 10.1093/nar/gkz401
Huang da, W., Sherman, B. T. & Lempicki, R. A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37, 1–13 (2009).
pubmed: 19033363 doi: 10.1093/nar/gkn923
Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947–1951 (2019).
pubmed: 31441146 pmcid: 6798127 doi: 10.1002/pro.3715
Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27–30 (2000).
pubmed: 10592173 pmcid: 102409 doi: 10.1093/nar/28.1.27
Kanehisa, M., Sato, Y., Furumichi, M., Morishima, K. & Tanabe, M. New approach for understanding genome variations in KEGG. Nucleic Acids Res. 47, D590–d595 (2019).
pubmed: 30321428 doi: 10.1093/nar/gky962
Priatel, J., Huang, Y.-H., Tsai, K., Harder, K. & Tan, R. SLAM-associated protein modulates CD8
Creelan, B. C. & Antonia, S. J. The NKG2A immune checkpoint—a new direction in cancer immunotherapy. Nat. Rev. Clin. Oncol. 16, 277–278 (2019).
pubmed: 30824813 doi: 10.1038/s41571-019-0182-8
Trapnell, C. et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat. Biotechnol. 32, 381–386 (2014).
pubmed: 24658644 pmcid: 4122333 doi: 10.1038/nbt.2859
Haghverdi, L., Büttner, M., Wolf, F. A., Buettner, F. & Theis, F. J. Diffusion pseudotime robustly reconstructs lineage branching. Nat. Methods 13, 845–848 (2016).
pubmed: 27571553 doi: 10.1038/nmeth.3971
Das, J. & Yu, H. HINT: High-quality protein interactomes and their applications in understanding human disease. BMC Syst. Biol. 6, 92 (2012).
pubmed: 22846459 pmcid: 3483187 doi: 10.1186/1752-0509-6-92
Cusick, M. E. et al. Literature-curated protein interaction datasets. Nat. Methods 6, 39–46 (2009).
pubmed: 19116613 pmcid: 2683745 doi: 10.1038/nmeth.1284
Kent, S. C. et al. Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope. Nature 435, 224–228 (2005).
pubmed: 15889096 doi: 10.1038/nature03625
Nakayama, M. et al. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 435, 220–223 (2005).
pubmed: 15889095 pmcid: 1364531 doi: 10.1038/nature03523
Krishnamurthy, B. et al. Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP. J. Clin. Invest. 116, 3258–3265 (2006).
pubmed: 17143333 pmcid: 1679712 doi: 10.1172/JCI29602
Prasad, S., Xu, D. & Miller, S. D. Tolerance strategies employing antigen-coupled apoptotic cells and carboxylated PLG nanoparticles for the treatment of type 1 diabetes. Rev. Diabet. Stud. 9, 319–327 (2012).
pubmed: 23804269 doi: 10.1900/RDS.2012.9.319
Amrani, A. et al. Progression of autoimmune diabetes driven by avidity maturation of a T cell population. Nature 406, 739–742 (2000).
pubmed: 10963600 doi: 10.1038/35021081
Woo, S. R. et al. Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T cell function to promote tumoral immune escape. Cancer Res. 72, 917–927 (2012).
pubmed: 22186141 doi: 10.1158/0008-5472.CAN-11-1620
Andrews, L. P. et al. Resistance to PD1 blockade in the absence of metalloprotease-mediated LAG3 shedding. Sci. Immunol. https://doi.org/10.1126/sciimmunol.abc2728 (2020).
Blackburn, S. D. et al. Coregulation of CD8
pubmed: 19043418 doi: 10.1038/ni.1679
Grebinoski, S. & Vignali, D. A. A. Inhibitory receptor agonists: the future of autoimmune disease therapeutics? Curr. Opin. Immunol. 67, 1–9 (2020).
pubmed: 32619929 pmcid: 7744338 doi: 10.1016/j.coi.2020.06.001
Jones, B. E. et al. Fewer LAG-3
Leiter, E. H. The NOD mouse: a model for insulin-dependent diabetes mellitus. Curr. Protoc. Immunol. 15, 15.19 (2001).
Rodriguez-Calvo, T., Ekwall, O., Amirian, N., Zapardiel-Gonzalo, J. & von Herrath, M. G. Increased immune cell infiltration of the exocrine pancreas: a possible contribution to the pathogenesis of type 1 diabetes. Diabetes 63, 3880–3890 (2014).
pubmed: 24947367 pmcid: 4207385 doi: 10.2337/db14-0549
Watson, M. J. et al. Metabolic support of tumour-infiltrating regulatory T cells by lactic acid. Nature 591, 645–651 (2021).
pubmed: 33589820 pmcid: 7990682 doi: 10.1038/s41586-020-03045-2
Roederer, M., Nozzi, J. L. & Nason, M. C. SPICE: exploration and analysis of post-cytometric complex multivariate datasets. Cytometry A 79, 167–174 (2011).
pubmed: 21265010 pmcid: 3072288 doi: 10.1002/cyto.a.21015
Pauken, K. E. et al. Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade. Science 354, 1160–1165 (2016).
pubmed: 27789795 pmcid: 5484795 doi: 10.1126/science.aaf2807
Picelli, S. et al. Smart-seq2 for sensitive full-length transcriptome profiling in single cells. Nat. Methods 10, 1096–1098 (2013).
pubmed: 24056875 doi: 10.1038/nmeth.2639
Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
pubmed: 23104886 doi: 10.1093/bioinformatics/bts635
Law, C. W., Chen, Y., Shi, W. & Smyth, G. K. voom: precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 15, R29 (2014).
pubmed: 24485249 pmcid: 4053721 doi: 10.1186/gb-2014-15-2-r29
Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).
pubmed: 25605792 pmcid: 4402510 doi: 10.1093/nar/gkv007
Smyth, G. K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3, 3 (2004).
doi: 10.2202/1544-6115.1027
Mootha, V. K. et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267–273 (2003).
pubmed: 12808457 doi: 10.1038/ng1180
Subramanian, A. et al. Gene-set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545–15550 (2005).
pubmed: 16199517 pmcid: 1239896 doi: 10.1073/pnas.0506580102
Doering, T. A. et al. Network analysis reveals centrally connected genes and pathways involved in CD8
pubmed: 23159438 pmcid: 3749234 doi: 10.1016/j.immuni.2012.08.021
Stoeckius, M. et al. Cell hashing with barcoded antibodies enables multiplexing and doublet detection for single cell genomics. Genome Biol. 19, 224 (2018).
pubmed: 30567574 pmcid: 6300015 doi: 10.1186/s13059-018-1603-1
Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888–1902 (2019).
pubmed: 31178118 pmcid: 6687398 doi: 10.1016/j.cell.2019.05.031
Cillo, A. R. et al. Immune landscape of viral- and carcinogen-driven head and neck cancer. Immunity 52, 183–199 (2020).
pubmed: 31924475 pmcid: 7201194 doi: 10.1016/j.immuni.2019.11.014
Becht, E. et al. Dimensionality reduction for visualizing single-cell data using UMAP. Nat. Biotechnol. 37, 38–44 (2019).
doi: 10.1038/nbt.4314
Wickham, H. ggplot2: Elegant Graphics for Data Analysis (Springer-Verlag, 2009).
Wickham, H. et al. Welcome to the Tidyverse. J. Open Source Softw. 4, 1686 (2019).
doi: 10.21105/joss.01686
Godec, J. et al. Compendium of immune signatures identifies conserved and species-specific biology in response to inflammation. Immunity 44, 194–206 (2016).
pubmed: 26795250 pmcid: 5330663 doi: 10.1016/j.immuni.2015.12.006
Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498–2504 (2003).
pubmed: 14597658 pmcid: 403769 doi: 10.1101/gr.1239303

Auteurs

Stephanie Grebinoski (S)

Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Graduate Program of Microbiology and Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Tumor Microenvironment Center, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.

Qianxia Zhang (Q)

Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Graduate Program of Microbiology and Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Tumor Microenvironment Center, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.
Program in Cellular and Molecular Medicine, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA.

Anthony R Cillo (AR)

Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Tumor Microenvironment Center, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.

Sasikanth Manne (S)

Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.

Hanxi Xiao (H)

Center for Systems Immunology, Departments of Immunology and Computational & Systems Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
CMU-Pitt Joint Computational Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.

Erin A Brunazzi (EA)

Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Tumor Microenvironment Center, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.

Tracy Tabib (T)

Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Carly Cardello (C)

Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Tumor Microenvironment Center, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.

Christine G Lian (CG)

Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

George F Murphy (GF)

Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Robert Lafyatis (R)

Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

E John Wherry (EJ)

Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Parker Institute for Cancer Immunotherapy at University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.

Jishnu Das (J)

Center for Systems Immunology, Departments of Immunology and Computational & Systems Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Creg J Workman (CJ)

Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Tumor Microenvironment Center, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.

Dario A A Vignali (DAA)

Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. dvignali@pitt.edu.
Tumor Microenvironment Center, UPMC Hillman Cancer Center, Pittsburgh, PA, USA. dvignali@pitt.edu.
Cancer Immunology and Immunotherapy Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA. dvignali@pitt.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH